The mission of the University of Massachusetts Medical School Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center for FSHD is to further our understanding of the underlying molecular, genetic and epigenetic pathologies of facioscapulohumeral muscular dystrophy (FSHD) and to translate this basic understanding into the clinic through development of FSHD therapeutics. To achieve this objective, the Wellstone Center has established a large repository of FSHD muscle tissue and derived muscle cells, available to FSHD researchers worldwide, and developed a FSHD disease biomarker database and new disease models for pre-clinical research to develop FSHD therapeutics for clinical trials. The Center, led by Dr. Charles P. Emerson at the University of Massachusetts Medical School and Dr. Louis Kunkel at Children's Hospital Boston, is an highly collaborative and multidisciplinary team of basic and clinical investigators with laboratories at the University of Massachusetts Medical School, Children’s Hospital Boston, and Kennedy Krieger Institute in Baltimore, and partnered with the FSH Society for patient outreach activities and with biotech industry for therapeutic development. This partnership of basic, clinical and industry scientists with FSHD patients and their families enables the Wellstone Center to make unique contributions towards development of new treatments for this devastating disease and to provide leadership for FSHD research world-wide. This collection showcases journal articles and other publications and presentations authored by researchers in the Wellstone Center for FSHD.

Follow


Publications from 2017

PDF

Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD), Eugenie Ansseau, Celine Vanderplanck, Armelle Wauters, Scott Q. Harper, Frederique Coppee, and Alexandra Belayew

Link

Bone Health in Facioscapulohumeral Muscular Dystrophy: A Cross-Sectional Study, Hema Chagarlamudi, Alastair Corbett, Marion Stoll, Genila Bibat, Carla Grosmann, Carly Matichak Stock, Nikia Stinson, Jay Shapiro, and Kathryn Wagner

Link

Validity of the 6 minute walk test in facioscapulohumeral muscular dystrophy, Katy Eichinger, Chad Heatwole, Susanne Heininger, Nikia Stinson, Carly Matichak Stock, Carla Grosmann, Kathryn R. Wagner, Rabi Tawil, Jeffrey M. Statland, and FSHD Clinical Trials Research Network

PDF

CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion, Haiwei Mou, Jordan L. Smith, Lingtao Peng, Jill Moore, Xiao-Ou Zhang, Chun-Qing Song, Ankur Sheel, Deniz M. Ozata, Yingxiang Li, Charles P. Emerson Jr., Erik J. Sontheimer, Melissa J. Moore, Zhiping Weng, and Wen Xue

Publications from 2016

PDF

Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation, Eugenie Ansseau, Jocelyn O. Eidahl, Celine Lancelot, Alexandra Tassin, Christel Matteotti, Cassandre Yip, Jian Liu, Baptiste Leroy, Celine Hubeau, Cecile Gerbaux, Samuel Cloet, Armelle Wauters, Sabrina Zorbo, Pierre Meyer, Isabelle Pirson, Dalila Laoudj-Chenivesse, Ruddy Wattiez, Scott Q. Harper, Alexandra Belayew, and Frederique Coppee

PDF

Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics, Jennifer C. J. Chen, Oliver D. King, Yuanfan Zhang, Nicholas P. Clayton, Carrie Spencer, Bruce M. Wentworth, Charles P. Emerson Jr., and Kathryn R. Wagner (Molecular therapy : the journal of the American Society of Gene Therapy)

Link

Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4, Jocelyn O. Eidahl, Carlee R. Giesige, Jacqueline S. Domire, Lindsay M. Wallace, Allison M. Fowler, Susan M. Guckes, Sara E. Garwick-Coppens, Paul Labhart, and Scott Q. Harper

Link

Muscle dysfunction in a zebrafish model of Duchenne muscular dystrophy, Jeffrey J. Widrick, Matthew Alexander, Benjamin Sanchez, Devin Gibbs, Genri Kawahara, Alan Beggs, and Louis Kunkel

Publications from 2015

PDF

Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy, Takako I. Jones, Oliver D. King, Charis L. Himeda, Sachiko Homma, Jennifer C. J. Chen, Mary Lou. Beermann, Chi Yan, Charles P. Emerson Jr., Jeffrey B. Miller, Kathryn R. Wagner, and Peter L. Jones

Link

Emerging preclinical animal models for FSHD, Angela Lek, Fedik Rahimov, Peter L. Jones, and Louis M. Kunkel

Publications from 2014

Link

Human skeletal muscle xenograft as a new preclinical model for muscle disorders, Yuanfan Zhang, Oliver D. King, Fedik Rahimov, Takako I. Jones, Christopher W. Ward, Jaclyn P. Kerr, Naili Liu, Charles P. Emerson Jr., Louis M. Kunkel, Terence A. Partridge, and Kathryn R. Wagner

Publications from 2013

PDF

Analysis of Myogenic and Candidate Disease Biomarkers in FSHD Muscle Cells, Jennifer C. J. Chen; Takako I. Jones; Oliver D. King; Kendal Hanger; Fedik Rahimov; Sachiko Homma; Mary Lou Beermann; Genila M. Bibat; Jeffrey B. Miller; Louise M. Kunkel; Kathryn R. Wagner; Peter L. Jones; and Charles P. Emerson, Jr.

PDF

Epigenetic variability is a modifier of facioscapulohumeral muscular dystrophy, Takako I. Jones; Chia-Yun Sun; Celine Debarnot; Charis Himeda; Charles P. Emerson, Jr.; and Peter L. Jones

PDF

Stress granules as crucibles of ALS pathogenesis, Yun R. Li, Oliver D. King, James Shorter, and Aaron D. Gitler

Link

Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy, Hiroaki Mitsuhashi, Satomi Mitsuhashi, Taylor Lynn-Jones, Genri Kawahara, and Louis M. Kunkel

Link

Telomere position effect regulates DUX4 in human facioscapulohumeral muscular dystrophy, Guido Stadler, Fedik Rahimov, Oliver D. King, Jennifer C. J. Chen, Jerome D. Robin, Kathryn R. Wagner, Jerry W. Shay, Charles P. Emerson Jr., and Woodring E. Wright

PDF

Dux4 Target Gene Expression in Mouse Muscle Transplanted with Muscle Cells from FSHD Patients, James A. Windelborn and Charles P. Emerson, Jr.

PDF

Immortalized myogenic cells from congenital muscular dystrophy type1A patients recapitulate aberrant caspase activation in pathogenesis: a new tool for MDC1A research, Soonsang Yoon, Guido Stadler, Mary Lou Beermann, Eric V. Schmidt, James A. Windelborn, Peter Schneiderat, Woodring E. Wright, and Jeffrey Boone Miller

Publications from 2012

Link

Facioscapulohumeral Muscular Dystrophy: Unraveling the Mysteries of a Complex Epigenetic Disease, Charis Himeda and Charles P. Emerson, Jr.

Link

Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis, Takako I. Jones; Jennifer Cj Chen; Fedik Rahimov; Sachiko Homma; Patricia Arashiro; Mary Lou Beermann; Oliver D. King; Jeffrey Boone Miller; Louis M. Kunkel; Charles P. Emerson, Jr.; Kathryn R. Wagner; and Peter L. Jones

Link

Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers, Fedik Rahimov, Oliver D. King, Doris G. Leung, Genila M. Bibat, Charles P. Emerson Jr., Louis M. Kunkel, and Kathryn R. Wagner

Link

Optimization of large gel 2D electrophoresis for proteomic studies of skeletal muscle, Patrick W. Reed, Allison Densmore, and Robert J. Bloch

Link

Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy, Isabella Scionti, Francesca Greco, Giulia Ricci, Monica Govi, Patricia Arashiro, Liliana Vercelli, Angela Berardinelli, Corrado Angelini, Giovanni Antonini, Michelangelo Cao, Antonio Di Muzio, Maurizio Moggio, Lucia Morandi, Enzo Ricci, Carmelo Rodolico, Lucia Ruggiero, Lucio Santoro, Gabriele Siciliano, Giuliano Tomelleri, Carlo Pietro Trevisan, Giuliana Galluzzi, Woodring E. Wright, Mayana Zatz, and Rossella Ginevra Tupler

Publications from 2011

Link

A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family, disease and cell function, Sachiko Homma; Jennifer Cj Chen; Fedik Rahimov; Mary Lou Beermann; Kendal Hanger; Genila M. Bibat; Kathryn R. Wagner; Louis M. Kunkel; Charles P. Emerson, Jr.; and Jeffrey Boone Miller

Link

Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor, Fedik Rahimov, Oliver D. King, Leigh C. Warsing, Rachel E. Powell, Charles P. Emerson Jr., Louis M. Kunkel, and Kathryn R. Wagner

Link

Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor, Fedik Rahimov; Oliver D. King; Leigh C. Warsing; Rachel E. Powell; Charles P. Emerson, Jr.; Louis M. Kunkel; and Kathryn R. Wagner

PDF

Establishment of clonal myogenic cell lines from severely affected dystrophic muscles - CDK4 maintains the myogenic population, Guido Stadler; Jennifer Cj Chen; Kathryn Wagner; Jerome D. Robin; Jerry W. Shay; Charles P. Emerson, Jr.; and Woodring E. Wright

Publications from 2009

PDF

Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers, Patricia Arashiro, Iris Eisenberg, Alvin T. Kho, Antonia M. P. Cerqueira, Marta Canovas, Helga C. A. Silva, Rita C. M. Pavanello, Sergio Verjovski-Almeida, Louis M. Kunkel, and Mayana Zatz